‘Not the Last of It,’ Says Investor About Palantir Stock

Palantir (PLTR) has seen its stock surge over 2,000% since early 2024, driven by AI and robust Q2 2025 results, including over $1 billion in revenue and 93% U.S. commercial growth, though it recently experienced a 15% pullback. Despite strong fundamentals and significant deal flow, its premium valuation remains a key concern, leading investor Daniel Jones to maintain a "strong sell" rating, asserting the stock won't be reasonably priced until 2028 even under aggressive growth assumptions. Wall Street analysts largely hold a cautious "Hold" consensus, with a modest 12-month price target.

Analysis

Palantir Technologies (PLTR) presents a classic case of a high-growth narrative conflicting with extreme valuation metrics. The company's stock has surged over 2,000% since the start of 2024, underpinned by strong fundamental performance including a landmark quarter with over $1 billion in revenue and a 93% year-over-year increase in its U.S. commercial business. This expansion beyond its core government contracts is supported by significant deal momentum, evidenced by 42 contracts valued at over $10 million each in Q2 2025. However, this operational success has driven the stock to a premium valuation that is now a primary point of concern. The recent 15% share price decline following a record high suggests valuation fears are materializing. This sentiment is echoed by analyst Daniel Jones, who projects that even with a sustained 60% annual revenue growth, the stock would not reach a reasonable price until 2028, leading to his 'strong sell' rating. The broader Wall Street consensus is a cautious 'Hold', with an average 12-month price target of $154.47 that implies minimal upside from current levels, reinforcing the view that the stock's price may have outpaced its near-term fundamental prospects.

Key Decisions for Investors

• Given the stock's 2,000% appreciation and stated concerns about its premium valuation, investors with significant gains may consider trimming their positions to de-risk and lock in profits.
• Potential investors should exercise caution, as the analysis suggests the stock is significantly overvalued and could face further declines; waiting for a more substantial pullback or for fundamentals to catch up to the price may be a prudent strategy.
• All investors should closely monitor the U.S. commercial revenue growth rate and the pace of large contract wins, as continued exceptional performance in these areas is critical to justifying the stock's current valuation premium.